Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 5—May 2025
CME ACTIVITY - Research

Nationwide Observational Case–Control Study of Risk Factors for Aerococcus Bloodstream Infections, Sweden

John WallesComments to Author , Malin Inghammar, Magnus Rasmussen, and Torgny Sunnerhagen
Author affiliation: Central Hospital Kristianstad, Kristianstad, Sweden (J. Walles); Lund University, Malmö, Sweden (J. Walles); Lund University, Lund, Sweden (J. Walles, M. Inghammar, M. Rasmussen, T. Sunnerhagen); Skåne University Hospital, Lund (J. Walles, M. Inghammar, M. Rasmussen, T. Sunnerhagen)

Main Article

Figure 1

Overview of data collection and curation in nationwide observational case–control study of risk factors for Aerococcus BSIs, Sweden. Cases of aerococcal BSI were identified at 19 clinical microbiological laboratories across Sweden during 2012–2016. Matched control data were obtained from the Swedish Population Register. Registered diagnoses were collected from the National Patient Register, and prescribed drug data were collected from the National Drug Register. Registrations performed 30–730 days before aerococcal BSI detection were used to define medical conditions and characteristics hypothesized to contribute to aerococcal BSI. ATC, Anatomic Therapeutic Chemical; BSI, bloodstream infection; ICD-10, International Classification of Diseases, 10th Revision.

Figure 1. Overview of data collection and curation in nationwide observational case–control study of risk factors for Aerococcus BSIs, Sweden. Cases of aerococcal BSI were identified at 19 clinical microbiological laboratories across Sweden during 2012–2016. Matched control data were obtained from the Swedish Population Register. Registered diagnoses were collected from the National Patient Register, and prescribed drug data were collected from the National Drug Register. Registrations performed 30–730 days before aerococcal BSI detection were used to define medical conditions and characteristics hypothesized to contribute to aerococcal BSI. ATC, Anatomic Therapeutic Chemical; BSI, bloodstream infection; ICD-10, International Classification of Diseases, 10th Revision.

Main Article

Page created: March 02, 2025
Page updated: April 23, 2025
Page reviewed: April 23, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external